{"DataElement":{"publicId":"2934413","version":"1","preferredName":"Data Name DatumName","preferredDefinition":"A collection of facts from which conclusions may be drawn._The words or language units by which a thing is known._The list of values for  data names of different characterization assays.","longName":"2640462v1.0:2934410v1.0","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"2640462","version":"1","preferredName":"Data Name","preferredDefinition":"A collection of facts from which conclusions may be drawn._The words or language units by which a thing is known.","longName":"2423506v1.0:2222841v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2423506","version":"1","preferredName":"Data","preferredDefinition":"A collection of facts from which conclusions may be drawn.","longName":"C25474","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Data","conceptCode":"C25474","definition":"A collection or single item of factual information, derived from measurement or research, from which conclusions may be drawn.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"04359B62-CC96-5BAE-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-28","endDate":null,"createdBy":"UMLLOADER_DUKE_P","dateCreated":"2005-10-28","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2222841","version":"1","preferredName":"Name","preferredDefinition":"The words or language units by which a thing is known.","longName":"C42614","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Name","conceptCode":"C42614","definition":"The words or language units by which a thing is known.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F6211245-8062-4DD9-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-02","endDate":null,"createdBy":"UMLLOADER_EVS","dateCreated":"2005-05-02","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2222502","version":"1","preferredName":"UML DEFAULT CD","preferredDefinition":"Default Conceptual Domain for UML Loader","longName":"UML DEFAULT CD","context":"caCORE","contextVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5E53F3B-47A4-52D1-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-04-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2005-04-29","modifiedBy":"DWARZEL","dateModified":"2021-04-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"30FFB53B-8932-162E-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-05-21","endDate":null,"createdBy":"UMLLOADER_LABKEYCPAS","dateCreated":"2007-05-21","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"8/12/2010 released at request of caLIMS2 model owner","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2934410","version":"1","preferredName":"DatumName","preferredDefinition":"The list of values for  data names of different characterization assays.","longName":"2934410v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":null,"minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"caspase 3 apoptosis: % of control","valueDescription":"Caspase-3 Apoptosis Percentage Control Group","ValueMeaning":{"publicId":"2915669","version":"1","preferredName":"Caspase-3 Apoptosis Percentage Control Group","longName":"2915669","preferredDefinition":"Caspase-3, encoded by the CASP3 gene, is a member of the cysteine-aspartic acid protease (caspase) family. Sequential activation of caspases plays a central role in the execution-phase of cell apoptosis. Caspases exist as inactive proenzymes which undergo proteolytic processing at conserved aspartic residues to produce 2 subunits, large and small, that dimerize to form the active enzyme. Caspase-3 is a central player in mediating apoptosis and is the most widely studied caspase. This protein cleaves and activates caspases 6, 7 and 9, and itself can be processed by caspases 8, 9 and 10. It is the predominant caspase involved in the cleavage of amyloid-beta 4A precursor protein, which is associated with neuronal death in Alzheimer's disease. Alternative splicing of the CASP3 gene results in two transcript variants which encode the same protein. (From LocusLink and NCI):An active process of selective destruction of differentiated cells in multicellular organisms, apoptosis is one of two mechanisms by which cell death occurs (the other being necrosis, a pathological process).  Important in ontogenesis, tumorigenesis, tissue turnover, lymphocyte selection and function, hormone-induced atrophy, etc., it serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth.  Apoptosis is responsible for physiological deletion of cells and appears to be intrinsically programmed.  It is characterized by distinctive morphologic changes in the nucleus and cytoplasm, including chromatin cleavage at regularly spaced sites and endonucleolytic cleavage of genomic DNA (DNA fragmentation) at internucleosomal sites.:A fraction or ratio with 100 understood as the denominator.:A group used as a standard of comparison in a control experiment.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Caspase-3","conceptCode":"C18031","definition":"Caspase-3 (277 aa, ~31 kDa) is encoded by the human CASP3 gene. This protein is involved in the mediation of proteolysis and the activation of apoptosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Apoptosis","conceptCode":"C17557","definition":"A form of programmed cell death that begins when a cell receives internal or external signals, then proceeds through a series of characteristic stages typically including rounding-up of the cell, retraction of pseudopods, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), and plasma membrane blebbing, and ends with the death of the cell.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Percentage","conceptCode":"C25613","definition":"A fraction or ratio with 100 understood as the denominator.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Control Group","conceptCode":"C28143","definition":"A group used as a standard of comparison in a control experiment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6E331B3E-7D7D-F896-E040-BB89AD433DA4","latestVersionIndicator":"Yes","beginDate":"2009-07-08","endDate":null,"createdBy":"UMLLOADER_CANANOLPRD","dateCreated":"2009-07-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7180DFAA-0BEF-2524-E040-BB89AD430F45","beginDate":null,"endDate":null,"createdBy":"UMLLOADER_CANANOLPRD","dateCreated":"2009-08-19","modifiedBy":"ONEDATA","dateModified":"2009-08-19","deletedIndicator":"No"},{"value":"caspase 3 apoptosis: fluorescence","valueDescription":"Caspase-3 Apoptosis Fluorescence","ValueMeaning":{"publicId":"2915670","version":"1","preferredName":"Caspase-3 Apoptosis Fluorescence","longName":"2915670","preferredDefinition":"Caspase-3, encoded by the CASP3 gene, is a member of the cysteine-aspartic acid protease (caspase) family. Sequential activation of caspases plays a central role in the execution-phase of cell apoptosis. Caspases exist as inactive proenzymes which undergo proteolytic processing at conserved aspartic residues to produce 2 subunits, large and small, that dimerize to form the active enzyme. Caspase-3 is a central player in mediating apoptosis and is the most widely studied caspase. This protein cleaves and activates caspases 6, 7 and 9, and itself can be processed by caspases 8, 9 and 10. It is the predominant caspase involved in the cleavage of amyloid-beta 4A precursor protein, which is associated with neuronal death in Alzheimer's disease. Alternative splicing of the CASP3 gene results in two transcript variants which encode the same protein. (From LocusLink and NCI):An active process of selective destruction of differentiated cells in multicellular organisms, apoptosis is one of two mechanisms by which cell death occurs (the other being necrosis, a pathological process).  Important in ontogenesis, tumorigenesis, tissue turnover, lymphocyte selection and function, hormone-induced atrophy, etc., it serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth.  Apoptosis is responsible for physiological deletion of cells and appears to be intrinsically programmed.  It is characterized by distinctive morphologic changes in the nucleus and cytoplasm, including chromatin cleavage at regularly spaced sites and endonucleolytic cleavage of genomic DNA (DNA fragmentation) at internucleosomal sites.:Fluorescence is a luminescence (i.e., optical phenomenon) in cold bodies, in which a molecule absorbs a high-energy photon, and re-emits it as a lower-energy (longer-wavelength) photon. The energy difference between the absorbed and emitted photons ends up as molecular vibrations (heat).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Caspase-3","conceptCode":"C18031","definition":"Caspase-3 (277 aa, ~31 kDa) is encoded by the human CASP3 gene. This protein is involved in the mediation of proteolysis and the activation of apoptosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Apoptosis","conceptCode":"C17557","definition":"A form of programmed cell death that begins when a cell receives internal or external signals, then proceeds through a series of characteristic stages typically including rounding-up of the cell, retraction of pseudopods, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), and plasma membrane blebbing, and ends with the death of the cell.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Fluorescence","conceptCode":"C16586","definition":"Fluorescence is a luminescence (i.e., optical phenomenon) in cold bodies, in which a molecule absorbs a high-energy photon, and re-emits it as a lower-energy (longer-wavelength) photon. The energy difference between the absorbed and emitted photons ends up as molecular vibrations (heat).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6E331B3E-7DA1-F896-E040-BB89AD433DA4","latestVersionIndicator":"Yes","beginDate":"2009-07-08","endDate":null,"createdBy":"UMLLOADER_CANANOLPRD","dateCreated":"2009-07-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7180DFAA-0C00-2524-E040-BB89AD430F45","beginDate":null,"endDate":null,"createdBy":"UMLLOADER_CANANOLPRD","dateCreated":"2009-08-19","modifiedBy":"ONEDATA","dateModified":"2009-08-19","deletedIndicator":"No"},{"value":"cell binding/internalization: cellular fluorescence","valueDescription":"Cell Endocytosis Cell Fluorescence","ValueMeaning":{"publicId":"2915671","version":"1","preferredName":"Cell Endocytosis Cell Fluorescence","longName":"2915671","preferredDefinition":"The smallest units of living structure capable of independent existence, composed of a membrane-enclosed mass of protoplasm and containing a nucleus or nucleoid.:Cellular uptake of extracellular materials within membrane-limited vacuoles or microvesicles. Endosomes play a central role in endocytosis.:The smallest units of living structure capable of independent existence, composed of a membrane-enclosed mass of protoplasm and containing a nucleus or nucleoid.:Fluorescence is a luminescence (i.e., optical phenomenon) in cold bodies, in which a molecule absorbs a high-energy photon, and re-emits it as a lower-energy (longer-wavelength) photon. The energy difference between the absorbed and emitted photons ends up as molecular vibrations (heat).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cell","conceptCode":"C12508","definition":"The smallest units of living structure capable of independent existence, composed of a membrane-enclosed mass of protoplasm and containing a nucleus or nucleoid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Endocytotic Process","conceptCode":"C16544","definition":"Cellular uptake of extracellular materials within membrane-limited vacuoles or microvesicles. Endosomes play a central role in endocytosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Cell","conceptCode":"C12508","definition":"The smallest units of living structure capable of independent existence, composed of a membrane-enclosed mass of protoplasm and containing a nucleus or nucleoid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Fluorescence","conceptCode":"C16586","definition":"Fluorescence is a luminescence (i.e., optical phenomenon) in cold bodies, in which a molecule absorbs a high-energy photon, and re-emits it as a lower-energy (longer-wavelength) photon. The energy difference between the absorbed and emitted photons ends up as molecular vibrations (heat).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6E331B3E-7DC6-F896-E040-BB89AD433DA4","latestVersionIndicator":"Yes","beginDate":"2009-07-08","endDate":null,"createdBy":"UMLLOADER_CANANOLPRD","dateCreated":"2009-07-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7180DFAA-0C11-2524-E040-BB89AD430F45","beginDate":null,"endDate":null,"createdBy":"UMLLOADER_CANANOLPRD","dateCreated":"2009-08-19","modifiedBy":"ONEDATA","dateModified":"2009-08-19","deletedIndicator":"No"},{"value":"CFU-GM: number of CFU-GM colonies","valueDescription":"Colony-Forming Unit-Granulocyte Macrophage Assay Value","ValueMeaning":{"publicId":"2915673","version":"1","preferredName":"Colony-Forming Unit-Granulocyte Macrophage Assay Value","longName":"2915673","preferredDefinition":"A functional (qualitative) as well as quantitative assay that is utilized as an indicator of granulopoiesis reconstitution.:A numerical quantity measured or assigned or computed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Colony-Forming Unit-Granulocyte Macrophage Assay","conceptCode":"C63799","definition":"A functional (qualitative) as well as quantitative assay that is utilized as an indicator of granulopoiesis reconstitution.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Value","conceptCode":"C25712","definition":"A numerical quantity measured or assigned or computed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6E331B3E-7E0D-F896-E040-BB89AD433DA4","latestVersionIndicator":"Yes","beginDate":"2009-07-08","endDate":null,"createdBy":"UMLLOADER_CANANOLPRD","dateCreated":"2009-07-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7180DFAA-0C2B-2524-E040-BB89AD430F45","beginDate":null,"endDate":null,"createdBy":"UMLLOADER_CANANOLPRD","dateCreated":"2009-08-19","modifiedBy":"ONEDATA","dateModified":"2009-08-19","deletedIndicator":"No"},{"value":"CFU-GM: total number of bone marrow cells","valueDescription":"Colony-Forming Unit-Granulocyte Macrophage Assay Bone Marrow Blood-Forming Cell Value","ValueMeaning":{"publicId":"2915674","version":"1","preferredName":"Colony-Forming Unit-Granulocyte Macrophage Assay Bone Marrow Blood-Forming Cell Value","longName":"2915674","preferredDefinition":"A functional (qualitative) as well as quantitative assay that is utilized as an indicator of granulopoiesis reconstitution.:Cells contained in the bone marrow including fat cells, stromal cells, mega karyocytes, and the immediate precursors of most blood cells. (MeSH):A numerical quantity measured or assigned or computed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Colony-Forming Unit-Granulocyte Macrophage Assay","conceptCode":"C63799","definition":"A functional (qualitative) as well as quantitative assay that is utilized as an indicator of granulopoiesis reconstitution.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Bone Marrow Blood-Forming Cell","conceptCode":"C12550","definition":"A hematopoietic stem cell found in the bone marrow.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Value","conceptCode":"C25712","definition":"A numerical quantity measured or assigned or computed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6E331B3E-7E31-F896-E040-BB89AD433DA4","latestVersionIndicator":"Yes","beginDate":"2009-07-08","endDate":null,"createdBy":"UMLLOADER_CANANOLPRD","dateCreated":"2009-07-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7180DFAA-0C34-2524-E040-BB89AD430F45","beginDate":null,"endDate":null,"createdBy":"UMLLOADER_CANANOLPRD","dateCreated":"2009-08-19","modifiedBy":"ONEDATA","dateModified":"2009-08-19","deletedIndicator":"No"},{"value":"chemotaxis: % of control","valueDescription":"Chemotaxis Percentage Control Group","ValueMeaning":{"publicId":"2915675","version":"1","preferredName":"Chemotaxis Percentage Control Group","longName":"2915675","preferredDefinition":"The characteristic directional movement or orientation of an organism or cell along a chemical concentration gradient either toward or away from the chemical stimulus.:A fraction or ratio with 100 understood as the denominator.:A group used as a standard of comparison in a control experiment.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chemotactic Process","conceptCode":"C16422","definition":"The characteristic directional movement or orientation of an organism or cell along a chemical concentration gradient either toward or away from the chemical stimulus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Percentage","conceptCode":"C25613","definition":"A fraction or ratio with 100 understood as the denominator.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Control Group","conceptCode":"C28143","definition":"A group used as a standard of comparison in a control experiment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6E331B3E-7E55-F896-E040-BB89AD433DA4","latestVersionIndicator":"Yes","beginDate":"2009-07-08","endDate":null,"createdBy":"UMLLOADER_CANANOLPRD","dateCreated":"2009-07-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7180DFAA-0C45-2524-E040-BB89AD430F45","beginDate":null,"endDate":null,"createdBy":"UMLLOADER_CANANOLPRD","dateCreated":"2009-08-19","modifiedBy":"ONEDATA","dateModified":"2009-08-19","deletedIndicator":"No"},{"value":"coagulation: activated partial thromboplastin time (APTT)","valueDescription":"Coagulation Partial Thromboplastin Time","ValueMeaning":{"publicId":"2915676","version":"1","preferredName":"Coagulation Partial Thromboplastin Time","longName":"2915676","preferredDefinition":"The process of clot formation.:This is a measurement of the intrinsic pathway of coagulation. Significant deficiency in factors II, V, VIII, IX, X, XI, XII or anticoagulants will prolong PTT. (BioTech Life Science Dictionary)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Coagulation","conceptCode":"C20812","definition":"The process of clot formation. (from On-line Medical Dictionary)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Activated Partial Thromboplastin Time","conceptCode":"C38462","definition":"A measurement of the length of time that it takes for clotting to occur when activating reagents are added to a plasma specimen. The test is partial due to the absence of tissue factor (Factor III) from the reaction mixture.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6E331B3E-7E78-F896-E040-BB89AD433DA4","latestVersionIndicator":"Yes","beginDate":"2009-07-08","endDate":null,"createdBy":"UMLLOADER_CANANOLPRD","dateCreated":"2009-07-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7180DFAA-0C56-2524-E040-BB89AD430F45","beginDate":null,"endDate":null,"createdBy":"UMLLOADER_CANANOLPRD","dateCreated":"2009-08-19","modifiedBy":"ONEDATA","dateModified":"2009-08-19","deletedIndicator":"No"},{"value":"coagulation: prothrombin time (PT)","valueDescription":"Coagulation Prothrombin Time","ValueMeaning":{"publicId":"2915677","version":"1","preferredName":"Coagulation Prothrombin Time","longName":"2915677","preferredDefinition":"The process of clot formation.:A measurement of the clotting time of plasma recalcified in the presence of excess tissue thromboplastin; it is a measure of the extrinsic pathway of coagulation. It is used to determine the clotting tendency of blood, in the measure of warfarin dosage, liver damage and vitamin K status. Factors measured are fibrinogen, prothrombin, and factors V, VII, and X.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Coagulation","conceptCode":"C20812","definition":"The process of clot formation. (from On-line Medical Dictionary)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Prothrombin Time","conceptCode":"C62656","definition":"A measurement of the clotting time of plasma recalcified in the presence of excess tissue thromboplastin; it is a measure of the extrinsic pathway of coagulation. It is used to determine the clotting tendency of blood, in the measure of warfarin dosage, liver damage and vitamin K status. Factors measured are fibrinogen, prothrombin, and factors V, VII, and X.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6E331B3E-7E9B-F896-E040-BB89AD433DA4","latestVersionIndicator":"Yes","beginDate":"2009-07-08","endDate":null,"createdBy":"UMLLOADER_CANANOLPRD","dateCreated":"2009-07-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7180DFAA-0C67-2524-E040-BB89AD430F45","beginDate":null,"endDate":null,"createdBy":"UMLLOADER_CANANOLPRD","dateCreated":"2009-08-19","modifiedBy":"ONEDATA","dateModified":"2009-08-19","deletedIndicator":"No"},{"value":"coagulation: reptilase time","valueDescription":"Coagulation Reptilase Time","ValueMeaning":{"publicId":"2915678","version":"1","preferredName":"Coagulation Reptilase Time","longName":"2915678","preferredDefinition":"The process of clot formation.:A measurement of the time it takes a plasma sample to clot after adding the snake venom enzyme batroxobin (reptilase). This procedure can be used to detect deficiencies or abnormalities in fibrinogen and this enzyme is resistant to both endogenous thrombin inhibitors and heparin.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Coagulation","conceptCode":"C20812","definition":"The process of clot formation. (from On-line Medical Dictionary)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Reptilase Time","conceptCode":"C80366","definition":"A measurement of the time it takes a plasma sample to clot after adding the snake venom enzyme batroxobin (reptilase). This procedure can be used to detect deficiencies or abnormalities in fibrinogen and this enzyme is resistant to both endogenous thrombin inhibitors and heparin.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6E331B3E-7EBE-F896-E040-BB89AD433DA4","latestVersionIndicator":"Yes","beginDate":"2009-07-08","endDate":null,"createdBy":"UMLLOADER_CANANOLPRD","dateCreated":"2009-07-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7180DFAA-0C78-2524-E040-BB89AD430F45","beginDate":null,"endDate":null,"createdBy":"UMLLOADER_CANANOLPRD","dateCreated":"2009-08-19","modifiedBy":"ONEDATA","dateModified":"2009-08-19","deletedIndicator":"No"},{"value":"coagulation: thrombin time","valueDescription":"Coagulation Thrombin Time","ValueMeaning":{"publicId":"2915679","version":"1","preferredName":"Coagulation Thrombin Time","longName":"2915679","preferredDefinition":"The process of clot formation.:A measurement of the time it takes a plasma sample to clot after adding the active enzyme thrombin.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Coagulation","conceptCode":"C20812","definition":"The process of clot formation. (from On-line Medical Dictionary)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Thrombin Time","conceptCode":"C80365","definition":"A measurement of the time it takes a plasma sample to clot after adding the active enzyme thrombin.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6E331B3E-7EE1-F896-E040-BB89AD433DA4","latestVersionIndicator":"Yes","beginDate":"2009-07-08","endDate":null,"createdBy":"UMLLOADER_CANANOLPRD","dateCreated":"2009-07-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7180DFAA-0C89-2524-E040-BB89AD430F45","beginDate":null,"endDate":null,"createdBy":"UMLLOADER_CANANOLPRD","dateCreated":"2009-08-19","modifiedBy":"ONEDATA","dateModified":"2009-08-19","deletedIndicator":"No"},{"value":"complement activation: is complement activation induced?","valueDescription":"Flag Complement Activation Above Threshold","ValueMeaning":{"publicId":"2915680","version":"1","preferredName":"Flag Complement Activation Above Threshold","longName":"2915680","preferredDefinition":"An indicator that can be set or unset in order to signal whether a particular condition is true.:The complement system consists of more than 30 proteins engaged in host defense. It provides both an independent immune system capable of attacking microbes as well as other foreign material and an adjunct to the antibody system. Once activated, the complement system fires in a cascade-like fashion in which one component activates the next. Both swift and powerful, millions of complement components can deposit on an invading microbe within only a few minutes. Such a potent system requires strict regulation to avoid host injury. Membrane cofactor protein (MCP) is one critical regulator aimed at controlling inadvertent complement activation on host cells and nearly every cell examined expresses MCP on its cell membrane.:In a place or position that is higher.:The lowest limit at which something becomes detectable or relevant.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Flag","conceptCode":"C43578","definition":"An indicator that can be set or unset in order to signal whether a particular condition is true.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Complement Activation","conceptCode":"C21519","definition":"Any physiologic process in which a protease directs the cleavage of complement components C4, C2, or factor B which then form the C3 and C5 convertases for the classical and lectin pathways, respectively. This process is involved in direct lysis of target cells, immune adherence and phagocytosis of pathogens, and recruitment and activation of immunocompetent cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Above","conceptCode":"C75329","definition":"In a place or position that is higher.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Threshold","conceptCode":"C48228","definition":"The lowest limit at which something becomes detectable or relevant.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6E331B3E-7F06-F896-E040-BB89AD433DA4","latestVersionIndicator":"Yes","beginDate":"2009-07-08","endDate":null,"createdBy":"UMLLOADER_CANANOLPRD","dateCreated":"2009-07-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7180DFAA-0C9A-2524-E040-BB89AD430F45","beginDate":null,"endDate":null,"createdBy":"UMLLOADER_CANANOLPRD","dateCreated":"2009-08-19","modifiedBy":"ONEDATA","dateModified":"2009-08-19","deletedIndicator":"No"},{"value":"cytokine induction: IL1 beta","valueDescription":"Cytokine Induction Interleukin-1-Beta","ValueMeaning":{"publicId":"2915681","version":"1","preferredName":"Cytokine Induction Interleukin-1-Beta","longName":"2915681","preferredDefinition":"A class of soluble glycoproteins which act nonenzymatically through specific receptors to regulate immune responses. Cytokines are derived from both immune and non-immune cells and are intercellular mediators that differ from hormones in that they are produced by a number of tissue or cell types rather than by specialized glands.:The act of bringing about something.:Interleukin-1 (endogenous pyrogen), produced primarily by monocytes, is an important pro-inflammatory cytokine that mediates the acute phase host response.  The biologic activities of IL1 are properties of a protein derived from a larger precursor.  Inflammation causes induction of COX2, leading to release of prostanoids, which sensitize peripheral nociceptor terminals and produce local pain hypersensitivity.  Inflammation also generates sensitivity in neighboring tissue, muscle and joint pain, fever, lethargy, and anorexia.  COX2 induction in regions of the CNS is mediated by IL1B.  Interleukin-1-beta also stimulates bone resorption.  IL1RN is a competitive inhibitor of IL1B.  Mature IL1-beta levels are a sensitive and specific indicator of caspase-1 activation.  (from OMIM 147720 and NCI)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cytokine","conceptCode":"C20464","definition":"A class of soluble glycoproteins which act nonenzymatically through specific receptors to regulate immune responses. Cytokines are derived from both immune and non-immune cells and are intercellular mediators that differ from hormones in that they are produced by a number of tissue or cell types rather than by specialized glands.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Induction","conceptCode":"C61367","definition":"The act of bringing about something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Interleukin-1 Beta","conceptCode":"C20522","definition":"Interleukin-1 beta (269 aa, ~31 kDa) is encoded by the human IL1B gene. This protein is involved in the macrophage-dependent inflammatory response.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6E331B3E-7F2A-F896-E040-BB89AD433DA4","latestVersionIndicator":"Yes","beginDate":"2009-07-08","endDate":null,"createdBy":"UMLLOADER_CANANOLPRD","dateCreated":"2009-07-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7180DFAA-0CAB-2524-E040-BB89AD430F45","beginDate":null,"endDate":null,"createdBy":"UMLLOADER_CANANOLPRD","dateCreated":"2009-08-19","modifiedBy":"ONEDATA","dateModified":"2009-08-19","deletedIndicator":"No"},{"value":"cytokine induction: IL10","valueDescription":"Cytokine Induction Interleukin-10","ValueMeaning":{"publicId":"2915682","version":"1","preferredName":"Cytokine Induction Interleukin-10","longName":"2915682","preferredDefinition":"A class of soluble glycoproteins which act nonenzymatically through specific receptors to regulate immune responses. Cytokines are derived from both immune and non-immune cells and are intercellular mediators that differ from hormones in that they are produced by a number of tissue or cell types rather than by specialized glands.:The act of bringing about something.:Expressed primarily in monocytes and less in lymphocytes by human IL10 Gene, Interleukin-10 is a cytokine with pleiotropic effects in immunoregulation and inflammation. It down-regulates expression of Th1 cytokines, MHC class II antigens, and costimulatory molecules on macrophages. It also enhances B cell survival, proliferation, and antibody production. This cytokine can block NF-kappa B activity, and is involved in the regulation of the JAK-STAT signaling pathway. Studies in mice suggest that this cytokine as an essential immunoregulator in the intestinal tract. (From LocusLink)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cytokine","conceptCode":"C20464","definition":"A class of soluble glycoproteins which act nonenzymatically through specific receptors to regulate immune responses. Cytokines are derived from both immune and non-immune cells and are intercellular mediators that differ from hormones in that they are produced by a number of tissue or cell types rather than by specialized glands.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Induction","conceptCode":"C61367","definition":"The act of bringing about something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Interleukin-10","conceptCode":"C20512","definition":"Interleukin-10 (178 aa, ~21 kDa) is encoded by the human IL10 gene. This protein plays a role in the negative regulation of cytokine expression.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6E331B3E-7F4E-F896-E040-BB89AD433DA4","latestVersionIndicator":"Yes","beginDate":"2009-07-08","endDate":null,"createdBy":"UMLLOADER_CANANOLPRD","dateCreated":"2009-07-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7180DFAA-0CBC-2524-E040-BB89AD430F45","beginDate":null,"endDate":null,"createdBy":"UMLLOADER_CANANOLPRD","dateCreated":"2009-08-19","modifiedBy":"ONEDATA","dateModified":"2009-08-19","deletedIndicator":"No"},{"value":"cytokine induction: IL6","valueDescription":"Cytokine Induction Interleukin-6","ValueMeaning":{"publicId":"2915683","version":"1","preferredName":"Cytokine Induction Interleukin-6","longName":"2915683","preferredDefinition":"A class of soluble glycoproteins which act nonenzymatically through specific receptors to regulate immune responses. Cytokines are derived from both immune and non-immune cells and are intercellular mediators that differ from hormones in that they are produced by a number of tissue or cell types rather than by specialized glands.:The act of bringing about something.:Produced by T-cells, monocytes, fibroblasts, and many other cells, Interleukin 6 stimulates the growth of hybridomas and plasmacytomas, as well as the growth and differentiation of B-cells.  Il6 increases synthesis and secretion of immunoglobulins by B-lymphocytes.  The biologic significance of IL6 lies in the fact that it is induced under conditions in which IFN-beta 1 is not induced, as in metabolically stressed cells.  Its induction by IL1 and TNF suggests that it may play a role as an autocrine mediator of these cytokines in inflammation and acute phase responses, as well as regulate cell proliferation.  In addition to its antiviral activity, IL6 elicits an acute phase response in liver cells and is identical to hepatocyte stimulatory factor.  (from OMIM 147620 and NCI)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cytokine","conceptCode":"C20464","definition":"A class of soluble glycoproteins which act nonenzymatically through specific receptors to regulate immune responses. Cytokines are derived from both immune and non-immune cells and are intercellular mediators that differ from hormones in that they are produced by a number of tissue or cell types rather than by specialized glands.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Induction","conceptCode":"C61367","definition":"The act of bringing about something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Interleukin-6","conceptCode":"C20451","definition":"Interleukin-6 (212 aa, ~24 kDa) is encoded by the human IL6 gene. This protein is involved in signaling affecting a wide variety of cell types including monocytes, lymphocytes, hepatocytes and nerve cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6E331B3E-7F72-F896-E040-BB89AD433DA4","latestVersionIndicator":"Yes","beginDate":"2009-07-08","endDate":null,"createdBy":"UMLLOADER_CANANOLPRD","dateCreated":"2009-07-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7180DFAA-0CCD-2524-E040-BB89AD430F45","beginDate":null,"endDate":null,"createdBy":"UMLLOADER_CANANOLPRD","dateCreated":"2009-08-19","modifiedBy":"ONEDATA","dateModified":"2009-08-19","deletedIndicator":"No"},{"value":"cytokine induction: IL8","valueDescription":"Cytokine Induction Interleukin-8","ValueMeaning":{"publicId":"2915684","version":"1","preferredName":"Cytokine Induction Interleukin-8","longName":"2915684","preferredDefinition":"A class of soluble glycoproteins which act nonenzymatically through specific receptors to regulate immune responses. Cytokines are derived from both immune and non-immune cells and are intercellular mediators that differ from hormones in that they are produced by a number of tissue or cell types rather than by specialized glands.:The act of bringing about something.:A member of the CXC chemokine family. This chemokine is one of the major mediators of the inflammatory response. This chemokine is secreted by several cell types including monocytes, macrophages, T-lymphocytes, fibroblasts, endothelial cells, and keratinocytes. It functions as a chemoattractant, and is also a potent angiogenic factor. (from LocusLink)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cytokine","conceptCode":"C20464","definition":"A class of soluble glycoproteins which act nonenzymatically through specific receptors to regulate immune responses. Cytokines are derived from both immune and non-immune cells and are intercellular mediators that differ from hormones in that they are produced by a number of tissue or cell types rather than by specialized glands.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Induction","conceptCode":"C61367","definition":"The act of bringing about something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Interleukin-8","conceptCode":"C20473","definition":"Interleukin-8 (99 aa, ~11 kDa) is encoded by the human CXCL8 gene. This protein is involved in chemotaxis and neutrophil activation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6E331B3E-7F96-F896-E040-BB89AD433DA4","latestVersionIndicator":"Yes","beginDate":"2009-07-08","endDate":null,"createdBy":"UMLLOADER_CANANOLPRD","dateCreated":"2009-07-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7180DFAA-0CDE-2524-E040-BB89AD430F45","beginDate":null,"endDate":null,"createdBy":"UMLLOADER_CANANOLPRD","dateCreated":"2009-08-19","modifiedBy":"ONEDATA","dateModified":"2009-08-19","deletedIndicator":"No"},{"value":"cytokine induction: TNF alpha","valueDescription":"Cytokine Induction Tumor Necrosis Factor-Alpha","ValueMeaning":{"publicId":"2915685","version":"1","preferredName":"Cytokine Induction Tumor Necrosis Factor-Alpha","longName":"2915685","preferredDefinition":"A class of soluble glycoproteins which act nonenzymatically through specific receptors to regulate immune responses. Cytokines are derived from both immune and non-immune cells and are intercellular mediators that differ from hormones in that they are produced by a number of tissue or cell types rather than by specialized glands.:The act of bringing about something.:Tumor Necrosis Factor (TNF) - Serum glycoprotein produced by activated macrophages and other mammalian mononuclear leukocytes which has necrotizing activity against tumor cell lines and increases ability to reject tumor transplants. It mimics the action of endotoxin but differs from it. It has a molecular weight of less than 70,000 kDa.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cytokine","conceptCode":"C20464","definition":"A class of soluble glycoproteins which act nonenzymatically through specific receptors to regulate immune responses. Cytokines are derived from both immune and non-immune cells and are intercellular mediators that differ from hormones in that they are produced by a number of tissue or cell types rather than by specialized glands.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Induction","conceptCode":"C61367","definition":"The act of bringing about something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Tumor Necrosis Factor","conceptCode":"C20535","definition":"Tumor necrosis factor (233 aa, ~26 kDa) is encoded by the human TNF gene. This protein is involved in the induction of cytokine expression, the stimulation of cell proliferation and the positive regulation of cell differentiation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6E331B3E-7FBA-F896-E040-BB89AD433DA4","latestVersionIndicator":"Yes","beginDate":"2009-07-08","endDate":null,"createdBy":"UMLLOADER_CANANOLPRD","dateCreated":"2009-07-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7180DFAA-0CEF-2524-E040-BB89AD430F45","beginDate":null,"endDate":null,"createdBy":"UMLLOADER_CANANOLPRD","dateCreated":"2009-08-19","modifiedBy":"ONEDATA","dateModified":"2009-08-19","deletedIndicator":"No"},{"value":"cytotoxic activity of NK cells: % of control","valueDescription":"Cytotoxicity Natural Killer Cell Percentage Control Group","ValueMeaning":{"publicId":"2915686","version":"1","preferredName":"Cytotoxicity Natural Killer Cell Percentage Control Group","longName":"2915686","preferredDefinition":"The adverse effect of some iatrogenic therapies. It is an accepted side effect in radiation therapy where the desired effect is to kill rapidly growing tumor cells.  In the killing of tumor cells, other cells that are rapidly growing e.g hair, mucous membranes are also killed.:Natural killer cells are cells that resemble large granular lymphocytes.  They do not express markers of either T or B cell lineage. They are positive for CD16, CD56, and CD 94.  These cells do possess Fc receptors for IgG and can kill target cells using antibody-dependent cell-mediated cytotoxicity. They can also use perforin to kill cells in the absence of antibody and killing may occur without previous sensitization.:A fraction or ratio with 100 understood as the denominator.:A group used as a standard of comparison in a control experiment.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cytotoxicity","conceptCode":"C27988","definition":"The adverse effect of some iatrogenic therapies. It is an accepted side effect in radiation therapy where the desired effect is to kill rapidly growing tumor cells.  In the killing of tumor cells, other cells that are rapidly growing e.g hair, mucous membranes are also killed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Natural Killer Cell","conceptCode":"C12536","definition":"Natural killer cells are cells that resemble large granular lymphocytes.  They do not express markers of either T or B cell lineage. They are positive for CD16, CD56, and CD 94.  These cells do possess Fc receptors for IgG and can kill target cells using antibody-dependent cell-mediated cytotoxicity. They can also use perforin to kill cells in the absence of antibody and killing may occur without previous sensitization.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Percentage","conceptCode":"C25613","definition":"A fraction or ratio with 100 understood as the denominator.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Control Group","conceptCode":"C28143","definition":"A group used as a standard of comparison in a control experiment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6E331B3E-7FDF-F896-E040-BB89AD433DA4","latestVersionIndicator":"Yes","beginDate":"2009-07-08","endDate":null,"createdBy":"UMLLOADER_CANANOLPRD","dateCreated":"2009-07-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7180DFAA-0D00-2524-E040-BB89AD430F45","beginDate":null,"endDate":null,"createdBy":"UMLLOADER_CANANOLPRD","dateCreated":"2009-08-19","modifiedBy":"ONEDATA","dateModified":"2009-08-19","deletedIndicator":"No"},{"value":"enzyme induction: % of control","valueDescription":"Enzyme Induction Percentage Control Group","ValueMeaning":{"publicId":"2915687","version":"1","preferredName":"Enzyme Induction Percentage Control Group","longName":"2915687","preferredDefinition":"Molecules that catalyze a chemical reaction. They are usually proteins, although catalytic RNA and DNA molecules have been identified.:The act of bringing about something.:A fraction or ratio with 100 understood as the denominator.:A group used as a standard of comparison in a control experiment.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Enzyme","conceptCode":"C16554","definition":"Molecules that catalyze a chemical reaction. They are usually proteins, although catalytic RNA and DNA molecules have been identified.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Induction","conceptCode":"C61367","definition":"The act of bringing about something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Percentage","conceptCode":"C25613","definition":"A fraction or ratio with 100 understood as the denominator.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Control Group","conceptCode":"C28143","definition":"A group used as a standard of comparison in a control experiment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6E331B3E-8004-F896-E040-BB89AD433DA4","latestVersionIndicator":"Yes","beginDate":"2009-07-08","endDate":null,"createdBy":"UMLLOADER_CANANOLPRD","dateCreated":"2009-07-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7180DFAA-0D11-2524-E040-BB89AD430F45","beginDate":null,"endDate":null,"createdBy":"UMLLOADER_CANANOLPRD","dateCreated":"2009-08-19","modifiedBy":"ONEDATA","dateModified":"2009-08-19","deletedIndicator":"No"},{"value":"gene expression: cellular fluorescence","valueDescription":"Gene Expression Cell Fluorescence","ValueMeaning":{"publicId":"2915688","version":"1","preferredName":"Gene Expression Cell Fluorescence","longName":"2915688","preferredDefinition":"Typically involves transcription of genetically encoded information into an intermediary message (messenger RNA) and subsequent translation into a functional protein.:The smallest units of living structure capable of independent existence, composed of a membrane-enclosed mass of protoplasm and containing a nucleus or nucleoid.:Fluorescence is a luminescence (i.e., optical phenomenon) in cold bodies, in which a molecule absorbs a high-energy photon, and re-emits it as a lower-energy (longer-wavelength) photon. The energy difference between the absorbed and emitted photons ends up as molecular vibrations (heat).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gene Expression","conceptCode":"C16608","definition":"Typically involves transcription of genetically encoded information into an intermediary message (messenger RNA) and subsequent translation into a functional protein.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Cell","conceptCode":"C12508","definition":"The smallest units of living structure capable of independent existence, composed of a membrane-enclosed mass of protoplasm and containing a nucleus or nucleoid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Fluorescence","conceptCode":"C16586","definition":"Fluorescence is a luminescence (i.e., optical phenomenon) in cold bodies, in which a molecule absorbs a high-energy photon, and re-emits it as a lower-energy (longer-wavelength) photon. The energy difference between the absorbed and emitted photons ends up as molecular vibrations (heat).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6E331B3E-8028-F896-E040-BB89AD433DA4","latestVersionIndicator":"Yes","beginDate":"2009-07-08","endDate":null,"createdBy":"UMLLOADER_CANANOLPRD","dateCreated":"2009-07-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7180DFAA-0D22-2524-E040-BB89AD430F45","beginDate":null,"endDate":null,"createdBy":"UMLLOADER_CANANOLPRD","dateCreated":"2009-08-19","modifiedBy":"ONEDATA","dateModified":"2009-08-19","deletedIndicator":"No"},{"value":"gene expression: fluorescence ratio","valueDescription":"Gene Expression Fluorescence Ratio Red Green","ValueMeaning":{"publicId":"2915689","version":"1","preferredName":"Gene Expression Fluorescence Ratio Red Green","longName":"2915689","preferredDefinition":"Typically involves transcription of genetically encoded information into an intermediary message (messenger RNA) and subsequent translation into a functional protein.:Fluorescence is a luminescence (i.e., optical phenomenon) in cold bodies, in which a molecule absorbs a high-energy photon, and re-emits it as a lower-energy (longer-wavelength) photon. The energy difference between the absorbed and emitted photons ends up as molecular vibrations (heat).:Quotient of quantities of the same kind for different components within the same system.:The hue of the long-wave end of the visible spectrum, evoked in the human observer by radiant energy with wavelengths of approximately 630 to 750 nanometers; any of a group of colors that may vary in lightness and saturation and whose hue resembles that of blood:The hue of that portion of the visible spectrum lying between yellow and blue, evoked in the human observer by radiant energy with wavelengths of approximately 490 to 570 nanometers; any of a group of colors that may vary in lightness and saturation and whose hue is that of the emerald or somewhat less yellow than that of growing grass.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gene Expression","conceptCode":"C16608","definition":"Typically involves transcription of genetically encoded information into an intermediary message (messenger RNA) and subsequent translation into a functional protein.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Fluorescence","conceptCode":"C16586","definition":"Fluorescence is a luminescence (i.e., optical phenomenon) in cold bodies, in which a molecule absorbs a high-energy photon, and re-emits it as a lower-energy (longer-wavelength) photon. The energy difference between the absorbed and emitted photons ends up as molecular vibrations (heat).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Ratio","conceptCode":"C44256","definition":"Quotient of quantities of the same kind for different components within the same system.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Red","conceptCode":"C48326","definition":"The hue of the long-wave end of the visible spectrum, evoked in the human observer by radiant energy with wavelengths of approximately 630 to 750 nanometers; any of a group of colors that may vary in lightness and saturation and whose hue resembles that of blood","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Green","conceptCode":"C48329","definition":"The hue of that portion of the visible spectrum lying between yellow and blue, evoked in the human observer by radiant energy with wavelengths of approximately 490 to 570 nanometers; any of a group of colors that may vary in lightness and saturation and whose hue is that of the emerald or somewhat less yellow than that of growing grass.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6E331B3E-804E-F896-E040-BB89AD433DA4","latestVersionIndicator":"Yes","beginDate":"2009-07-08","endDate":null,"createdBy":"UMLLOADER_CANANOLPRD","dateCreated":"2009-07-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7180DFAA-0D33-2524-E040-BB89AD430F45","beginDate":null,"endDate":null,"createdBy":"UMLLOADER_CANANOLPRD","dateCreated":"2009-08-19","modifiedBy":"ONEDATA","dateModified":"2009-08-19","deletedIndicator":"No"},{"value":"hemolysis: is hemolytic?","valueDescription":"Hemolysis Flag","ValueMeaning":{"publicId":"2915691","version":"1","preferredName":"Hemolysis Flag","longName":"2915691","preferredDefinition":"Disruption of the integrity of the erythrocyte membrane causing release of hemoglobin.:An indicator that can be set or unset in order to signal whether a particular condition is true.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hemolysis","conceptCode":"C37965","definition":"Disruption of the integrity of the erythrocyte membrane causing release of hemoglobin.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Flag","conceptCode":"C43578","definition":"An indicator that can be set or unset in order to signal whether a particular condition is true.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6E331B3E-8096-F896-E040-BB89AD433DA4","latestVersionIndicator":"Yes","beginDate":"2009-07-08","endDate":null,"createdBy":"UMLLOADER_CANANOLPRD","dateCreated":"2009-07-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7180DFAA-0D55-2524-E040-BB89AD430F45","beginDate":null,"endDate":null,"createdBy":"UMLLOADER_CANANOLPRD","dateCreated":"2009-08-19","modifiedBy":"ONEDATA","dateModified":"2009-08-19","deletedIndicator":"No"},{"value":"leukocyte proliferation: % of control","valueDescription":"Leukocyte Proliferation Percentage Control Group","ValueMeaning":{"publicId":"2915692","version":"1","preferredName":"Leukocyte Proliferation Percentage Control Group","longName":"2915692","preferredDefinition":"Blood cells that are devoid of hemoglobin, capable of ameboid motion and phagocytosis, and act as the principal components of the immune system.:Growth and reproduction of new similar forms, e.g. cells, buds, or offspring.:A fraction or ratio with 100 understood as the denominator.:A group used as a standard of comparison in a control experiment.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Leukocyte","conceptCode":"C12529","definition":"Blood cells that are devoid of hemoglobin, capable of ameboid motion and phagocytosis, and act as the principal components of the immune system.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Proliferation","conceptCode":"C37897","definition":"Proliferation; a rapid increase in number.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Percentage","conceptCode":"C25613","definition":"A fraction or ratio with 100 understood as the denominator.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Control Group","conceptCode":"C28143","definition":"A group used as a standard of comparison in a control experiment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6E331B3E-80BB-F896-E040-BB89AD433DA4","latestVersionIndicator":"Yes","beginDate":"2009-07-08","endDate":null,"createdBy":"UMLLOADER_CANANOLPRD","dateCreated":"2009-07-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7180DFAA-0D66-2524-E040-BB89AD430F45","beginDate":null,"endDate":null,"createdBy":"UMLLOADER_CANANOLPRD","dateCreated":"2009-08-19","modifiedBy":"ONEDATA","dateModified":"2009-08-19","deletedIndicator":"No"},{"value":"lipid peroxidation: % of control","valueDescription":"Lipid Peroxidation Percentage Control Group","ValueMeaning":{"publicId":"2915693","version":"1","preferredName":"Lipid Peroxidation Percentage Control Group","longName":"2915693","preferredDefinition":"The degradation of lipids caused by an oxidative attack from free radicals.:A fraction or ratio with 100 understood as the denominator.:A group used as a standard of comparison in a control experiment.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lipid Peroxidation","conceptCode":"C81870","definition":"The degradation of lipids caused by an oxidative attack from free radicals.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Percentage","conceptCode":"C25613","definition":"A fraction or ratio with 100 understood as the denominator.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Control Group","conceptCode":"C28143","definition":"A group used as a standard of comparison in a control experiment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6E331B3E-80DF-F896-E040-BB89AD433DA4","latestVersionIndicator":"Yes","beginDate":"2009-07-08","endDate":null,"createdBy":"UMLLOADER_CANANOLPRD","dateCreated":"2009-07-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7180DFAA-0D77-2524-E040-BB89AD430F45","beginDate":null,"endDate":null,"createdBy":"UMLLOADER_CANANOLPRD","dateCreated":"2009-08-19","modifiedBy":"ONEDATA","dateModified":"2009-08-19","deletedIndicator":"No"},{"value":"mitochondrial function: luminescence","valueDescription":"Mitochondrion Function Luminescence","ValueMeaning":{"publicId":"2915694","version":"1","preferredName":"Mitochondrion Function Luminescence","longName":"2915694","preferredDefinition":"Semiautonomous, self-reproducing organelles that occur in the cytoplasm of all cells of most, but not all, eukaryotes. Mitochondria contain distinctive ribosomes, transfer RNAs, amino acyl t-RNA synthetases, and elongation and termination factors. Mitochondria depend upon genes within the nucleus for many essential messenger RNAs. Mitochondria consist of two sets of membranes, a smooth continuous outer coat and an inner membrane arranged in tubules or more often in folds that form platelike double membranes (cristae). Mitochondria are the principal energy source of the cell and contains the cytochrome enzymes of terminal electron transport and the enzymes of the citric acid cycle, fatty acid oxidation, and oxidative phosphorylation. Mitochondria are the sites of the reactions of oxidative phosphorylation, which result in the formation of ATP.:The normal action performed by a structure or device.:The emission of light that does not involve the release of heat.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mitochondrion","conceptCode":"C13258","definition":"Semiautonomous, self-reproducing organelles that occur in the cytoplasm of all cells of most, but not all, eukaryotes. Mitochondria contain distinctive ribosomes, transfer RNAs, amino acyl t-RNA synthetases, and elongation and termination factors. Mitochondria depend upon genes within the nucleus for many essential messenger RNAs. Mitochondria consist of two sets of membranes, a smooth continuous outer coat and an inner membrane arranged in tubules or more often in folds that form platelike double membranes (cristae). Mitochondria are the principal energy source of the cell and contains the cytochrome enzymes of terminal electron transport and the enzymes of the citric acid cycle, fatty acid oxidation, and oxidative phosphorylation. Mitochondria are the sites of the reactions of oxidative phosphorylation, which result in the formation of ATP.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Function","conceptCode":"C25518","definition":"The normal action performed by a structure or device.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Luminescence","conceptCode":"C81012","definition":"The emission of light that does not involve the release of heat.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6E331B3E-8103-F896-E040-BB89AD433DA4","latestVersionIndicator":"Yes","beginDate":"2009-07-08","endDate":null,"createdBy":"UMLLOADER_CANANOLPRD","dateCreated":"2009-07-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7180DFAA-0D88-2524-E040-BB89AD430F45","beginDate":null,"endDate":null,"createdBy":"UMLLOADER_CANANOLPRD","dateCreated":"2009-08-19","modifiedBy":"ONEDATA","dateModified":"2009-08-19","deletedIndicator":"No"},{"value":"mitochondrial membrane potential: fluorescence ratio","valueDescription":"Mitochondrion Membrane Potential Fluorescence Ratio Percentage Control Group","ValueMeaning":{"publicId":"2915695","version":"1","preferredName":"Mitochondrion Membrane Potential Fluorescence Ratio Percentage Control Group","longName":"2915695","preferredDefinition":"Semiautonomous, self-reproducing organelles that occur in the cytoplasm of all cells of most, but not all, eukaryotes. Mitochondria contain distinctive ribosomes, transfer RNAs, amino acyl t-RNA synthetases, and elongation and termination factors. Mitochondria depend upon genes within the nucleus for many essential messenger RNAs. Mitochondria consist of two sets of membranes, a smooth continuous outer coat and an inner membrane arranged in tubules or more often in folds that form platelike double membranes (cristae). Mitochondria are the principal energy source of the cell and contains the cytochrome enzymes of terminal electron transport and the enzymes of the citric acid cycle, fatty acid oxidation, and oxidative phosphorylation. Mitochondria are the sites of the reactions of oxidative phosphorylation, which result in the formation of ATP.:The electrical potential difference across a plasma membrane.:Fluorescence is a luminescence (i.e., optical phenomenon) in cold bodies, in which a molecule absorbs a high-energy photon, and re-emits it as a lower-energy (longer-wavelength) photon. The energy difference between the absorbed and emitted photons ends up as molecular vibrations (heat).:Quotient of quantities of the same kind for different components within the same system.:A fraction or ratio with 100 understood as the denominator.:A group used as a standard of comparison in a control experiment.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mitochondrion","conceptCode":"C13258","definition":"Semiautonomous, self-reproducing organelles that occur in the cytoplasm of all cells of most, but not all, eukaryotes. Mitochondria contain distinctive ribosomes, transfer RNAs, amino acyl t-RNA synthetases, and elongation and termination factors. Mitochondria depend upon genes within the nucleus for many essential messenger RNAs. Mitochondria consist of two sets of membranes, a smooth continuous outer coat and an inner membrane arranged in tubules or more often in folds that form platelike double membranes (cristae). Mitochondria are the principal energy source of the cell and contains the cytochrome enzymes of terminal electron transport and the enzymes of the citric acid cycle, fatty acid oxidation, and oxidative phosphorylation. Mitochondria are the sites of the reactions of oxidative phosphorylation, which result in the formation of ATP.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"5"},{"longName":"Membrane Potential","conceptCode":"C82324","definition":"The electrical potential difference across a plasma membrane.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Fluorescence","conceptCode":"C16586","definition":"Fluorescence is a luminescence (i.e., optical phenomenon) in cold bodies, in which a molecule absorbs a high-energy photon, and re-emits it as a lower-energy (longer-wavelength) photon. The energy difference between the absorbed and emitted photons ends up as molecular vibrations (heat).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Ratio","conceptCode":"C44256","definition":"Quotient of quantities of the same kind for different components within the same system.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Percentage","conceptCode":"C25613","definition":"A fraction or ratio with 100 understood as the denominator.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Control Group","conceptCode":"C28143","definition":"A group used as a standard of comparison in a control experiment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6E331B3E-812A-F896-E040-BB89AD433DA4","latestVersionIndicator":"Yes","beginDate":"2009-07-08","endDate":null,"createdBy":"UMLLOADER_CANANOLPRD","dateCreated":"2009-07-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7180DFAA-0D99-2524-E040-BB89AD430F45","beginDate":null,"endDate":null,"createdBy":"UMLLOADER_CANANOLPRD","dateCreated":"2009-08-19","modifiedBy":"ONEDATA","dateModified":"2009-08-19","deletedIndicator":"No"},{"value":"mitochondrial membrane potential: ratio of red to green fluorescence","valueDescription":"Mitochondrion Membrane Potential Fluorescence Ratio Red Green","ValueMeaning":{"publicId":"2915696","version":"1","preferredName":"Mitochondrion Membrane Potential Fluorescence Ratio Red Green","longName":"2915696","preferredDefinition":"Semiautonomous, self-reproducing organelles that occur in the cytoplasm of all cells of most, but not all, eukaryotes. Mitochondria contain distinctive ribosomes, transfer RNAs, amino acyl t-RNA synthetases, and elongation and termination factors. Mitochondria depend upon genes within the nucleus for many essential messenger RNAs. Mitochondria consist of two sets of membranes, a smooth continuous outer coat and an inner membrane arranged in tubules or more often in folds that form platelike double membranes (cristae). Mitochondria are the principal energy source of the cell and contains the cytochrome enzymes of terminal electron transport and the enzymes of the citric acid cycle, fatty acid oxidation, and oxidative phosphorylation. Mitochondria are the sites of the reactions of oxidative phosphorylation, which result in the formation of ATP.:The electrical potential difference across a plasma membrane.:Fluorescence is a luminescence (i.e., optical phenomenon) in cold bodies, in which a molecule absorbs a high-energy photon, and re-emits it as a lower-energy (longer-wavelength) photon. The energy difference between the absorbed and emitted photons ends up as molecular vibrations (heat).:Quotient of quantities of the same kind for different components within the same system.:The hue of the long-wave end of the visible spectrum, evoked in the human observer by radiant energy with wavelengths of approximately 630 to 750 nanometers; any of a group of colors that may vary in lightness and saturation and whose hue resembles that of blood:The hue of that portion of the visible spectrum lying between yellow and blue, evoked in the human observer by radiant energy with wavelengths of approximately 490 to 570 nanometers; any of a group of colors that may vary in lightness and saturation and whose hue is that of the emerald or somewhat less yellow than that of growing grass.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mitochondrion","conceptCode":"C13258","definition":"Semiautonomous, self-reproducing organelles that occur in the cytoplasm of all cells of most, but not all, eukaryotes. Mitochondria contain distinctive ribosomes, transfer RNAs, amino acyl t-RNA synthetases, and elongation and termination factors. Mitochondria depend upon genes within the nucleus for many essential messenger RNAs. Mitochondria consist of two sets of membranes, a smooth continuous outer coat and an inner membrane arranged in tubules or more often in folds that form platelike double membranes (cristae). Mitochondria are the principal energy source of the cell and contains the cytochrome enzymes of terminal electron transport and the enzymes of the citric acid cycle, fatty acid oxidation, and oxidative phosphorylation. Mitochondria are the sites of the reactions of oxidative phosphorylation, which result in the formation of ATP.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"5"},{"longName":"Membrane Potential","conceptCode":"C82324","definition":"The electrical potential difference across a plasma membrane.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Fluorescence","conceptCode":"C16586","definition":"Fluorescence is a luminescence (i.e., optical phenomenon) in cold bodies, in which a molecule absorbs a high-energy photon, and re-emits it as a lower-energy (longer-wavelength) photon. The energy difference between the absorbed and emitted photons ends up as molecular vibrations (heat).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Ratio","conceptCode":"C44256","definition":"Quotient of quantities of the same kind for different components within the same system.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Red","conceptCode":"C48326","definition":"The hue of the long-wave end of the visible spectrum, evoked in the human observer by radiant energy with wavelengths of approximately 630 to 750 nanometers; any of a group of colors that may vary in lightness and saturation and whose hue resembles that of blood","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Green","conceptCode":"C48329","definition":"The hue of that portion of the visible spectrum lying between yellow and blue, evoked in the human observer by radiant energy with wavelengths of approximately 490 to 570 nanometers; any of a group of colors that may vary in lightness and saturation and whose hue is that of the emerald or somewhat less yellow than that of growing grass.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6E331B3E-8151-F896-E040-BB89AD433DA4","latestVersionIndicator":"Yes","beginDate":"2009-07-08","endDate":null,"createdBy":"UMLLOADER_CANANOLPRD","dateCreated":"2009-07-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7180DFAA-0DAA-2524-E040-BB89AD430F45","beginDate":null,"endDate":null,"createdBy":"UMLLOADER_CANANOLPRD","dateCreated":"2009-08-19","modifiedBy":"ONEDATA","dateModified":"2009-08-19","deletedIndicator":"No"},{"value":"molecular weight: molecular weight","valueDescription":"Molecular Weight","ValueMeaning":{"publicId":"2915697","version":"1","preferredName":"Molecular Weight","longName":"2915697","preferredDefinition":"The sum of the relative atomic masses of the constituent atoms of a molecule.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Molecular Weight","conceptCode":"C43521","definition":"The molecular mass of a substance is the sum of the relative atomic masses of the constituent atoms of a molecule.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6E331B3E-8173-F896-E040-BB89AD433DA4","latestVersionIndicator":"Yes","beginDate":"2009-07-08","endDate":null,"createdBy":"UMLLOADER_CANANOLPRD","dateCreated":"2009-07-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7180DFAA-0DBB-2524-E040-BB89AD430F45","beginDate":null,"endDate":null,"createdBy":"UMLLOADER_CANANOLPRD","dateCreated":"2009-08-19","modifiedBy":"ONEDATA","dateModified":"2009-08-19","deletedIndicator":"No"},{"value":"oxidative burst: % of control","valueDescription":"Oxidative Burst Percentage Control Group","ValueMeaning":{"publicId":"2915698","version":"1","preferredName":"Oxidative Burst Percentage Control Group","longName":"2915698","preferredDefinition":"A process that consists of the rapid release of reactive oxygen species. The process frequently ocurrs in cells when superoxide radical and hydrogen peroxide species are released.:A fraction or ratio with 100 understood as the denominator.:A group used as a standard of comparison in a control experiment.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Oxidative Burst","conceptCode":"C63849","definition":"A process that consists of the rapid release of reactive oxygen species. The process frequently ocurrs in cells when superoxide radical and hydrogen peroxide species are released.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Percentage","conceptCode":"C25613","definition":"A fraction or ratio with 100 understood as the denominator.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Control Group","conceptCode":"C28143","definition":"A group used as a standard of comparison in a control experiment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6E331B3E-8197-F896-E040-BB89AD433DA4","latestVersionIndicator":"Yes","beginDate":"2009-07-08","endDate":null,"createdBy":"UMLLOADER_CANANOLPRD","dateCreated":"2009-07-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7180DFAA-0DCC-2524-E040-BB89AD430F45","beginDate":null,"endDate":null,"createdBy":"UMLLOADER_CANANOLPRD","dateCreated":"2009-08-19","modifiedBy":"ONEDATA","dateModified":"2009-08-19","deletedIndicator":"No"},{"value":"phagocytosis: fold change vs. control","valueDescription":"Phagocytosis Fold Change Control Group","ValueMeaning":{"publicId":"2915699","version":"1","preferredName":"Phagocytosis Fold Change Control Group","longName":"2915699","preferredDefinition":"Phagocytosis; the process by which phagocytes engulf and digest microorganisms and cellular debris; an important defense against infection.:An indication of the magnitude difference between two values specified as the number of multiples of the first value to the second value (e.g., from 10 to 20 is a 2-fold increase, from 10 to 50 is a five-fold increase).:A group used as a standard of comparison in a control experiment.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Phagocytosis","conceptCode":"C26115","definition":"The process by which phagocytes engulf and digest microorganisms and cellular debris; an important defense against infection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Fold Change","conceptCode":"C60693","definition":"An indication of the magnitude difference between two values specified as the number of multiples of the first value to the second value (e.g., from 10 to 20 is a 2-fold increase, from 10 to 50 is a five-fold increase).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Control Group","conceptCode":"C28143","definition":"A group used as a standard of comparison in a control experiment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6E331B3E-81BB-F896-E040-BB89AD433DA4","latestVersionIndicator":"Yes","beginDate":"2009-07-08","endDate":null,"createdBy":"UMLLOADER_CANANOLPRD","dateCreated":"2009-07-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7180DFAA-0DDD-2524-E040-BB89AD430F45","beginDate":null,"endDate":null,"createdBy":"UMLLOADER_CANANOLPRD","dateCreated":"2009-08-19","modifiedBy":"ONEDATA","dateModified":"2009-08-19","deletedIndicator":"No"},{"value":"plasma protein binding: peptide bound","valueDescription":"Serum Protein Molecular Interaction Peptide","ValueMeaning":{"publicId":"2915700","version":"1","preferredName":"Serum Protein Molecular Interaction Peptide","longName":"2915700","preferredDefinition":"Dissolved proteins of blood plasma.  These mainly consist of albumins and globulins and include antibodies and blood-clotting proteins.:Involves temporary, non-covalent binding of two or more molecules as a result of intermolecular physical forces and often involves spatial complementarity between the interacting objects.:Organic compound composed of amino acids linked together chemically by peptide bonds. The peptide bond always involves a single covalent link between the alpha-carboxyl (oxygen-bearing carbon) of one amino acid and the amino nitrogen of a second amino acid.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Serum Protein","conceptCode":"C17126","definition":"Dissolved proteins of blood plasma.  These mainly consist of albumins and globulins and include antibodies and blood-clotting proteins.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Molecular Interaction Process","conceptCode":"C18219","definition":"Involves temporary, non-covalent binding of two or more molecules as a result of intermolecular physical forces and often involves spatial complementarity between the interacting objects.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Peptide","conceptCode":"C735","definition":"A compound of two or more amino acids where the alpha carboxyl group of one is bound to the alpha amino group of another.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6E331B3E-81DF-F896-E040-BB89AD433DA4","latestVersionIndicator":"Yes","beginDate":"2009-07-08","endDate":null,"createdBy":"UMLLOADER_CANANOLPRD","dateCreated":"2009-07-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7180DFAA-0DEE-2524-E040-BB89AD430F45","beginDate":null,"endDate":null,"createdBy":"UMLLOADER_CANANOLPRD","dateCreated":"2009-08-19","modifiedBy":"ONEDATA","dateModified":"2009-08-19","deletedIndicator":"No"},{"value":"plasma protein binding: protein bound","valueDescription":"Serum Protein Molecular Interaction Protein","ValueMeaning":{"publicId":"2915701","version":"1","preferredName":"Serum Protein Molecular Interaction Protein","longName":"2915701","preferredDefinition":"Dissolved proteins of blood plasma.  These mainly consist of albumins and globulins and include antibodies and blood-clotting proteins.:Involves temporary, non-covalent binding of two or more molecules as a result of intermolecular physical forces and often involves spatial complementarity between the interacting objects.:A group of complex organic macromolecules composed of one or more chains (linear polymers) of alpha-L-amino acids linked by peptide bonds and ranging in size from a few thousand to over 1 million Daltons. Proteins are fundamental genetically encoded components of living cells with specific structures and functions dictated by amino acid sequence.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Serum Protein","conceptCode":"C17126","definition":"Dissolved proteins of blood plasma.  These mainly consist of albumins and globulins and include antibodies and blood-clotting proteins.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Molecular Interaction Process","conceptCode":"C18219","definition":"Involves temporary, non-covalent binding of two or more molecules as a result of intermolecular physical forces and often involves spatial complementarity between the interacting objects.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Protein","conceptCode":"C17021","definition":"A group of complex organic macromolecules composed of one or more chains (linear polymers) of alpha-L-amino acids linked by peptide bonds and ranging in size from a few thousand to over 1 million Daltons. Proteins are fundamental genetically encoded components of living cells with specific structures and functions dictated by amino acid sequence.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6E331B3E-8203-F896-E040-BB89AD433DA4","latestVersionIndicator":"Yes","beginDate":"2009-07-08","endDate":null,"createdBy":"UMLLOADER_CANANOLPRD","dateCreated":"2009-07-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7180DFAA-0DFF-2524-E040-BB89AD430F45","beginDate":null,"endDate":null,"createdBy":"UMLLOADER_CANANOLPRD","dateCreated":"2009-08-19","modifiedBy":"ONEDATA","dateModified":"2009-08-19","deletedIndicator":"No"},{"value":"platelet aggregation: % of aggregation vs. control","valueDescription":"Platelet Aggregation Percentage Control Group","ValueMeaning":{"publicId":"2915702","version":"1","preferredName":"Platelet Aggregation Percentage Control Group","longName":"2915702","preferredDefinition":"The accumulation and adherence of platelets to form a clot or thrombus. When injury or bleeding occurs, platelets clump together at the site of injury; they expand and adhere to the injured area, thereby acting as a plug to reduce the bleeding. Platelet dysfunction can result in blood clotting and bleeding disorders.:A fraction or ratio with 100 understood as the denominator.:A group used as a standard of comparison in a control experiment.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Platelet Aggregation Process","conceptCode":"C16999","definition":"Any cell adhesion process that involves the association of platelets via adhesion molecules.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Percentage","conceptCode":"C25613","definition":"A fraction or ratio with 100 understood as the denominator.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Control Group","conceptCode":"C28143","definition":"A group used as a standard of comparison in a control experiment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6E331B3E-8227-F896-E040-BB89AD433DA4","latestVersionIndicator":"Yes","beginDate":"2009-07-08","endDate":null,"createdBy":"UMLLOADER_CANANOLPRD","dateCreated":"2009-07-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7180DFAA-0E10-2524-E040-BB89AD430F45","beginDate":null,"endDate":null,"createdBy":"UMLLOADER_CANANOLPRD","dateCreated":"2009-08-19","modifiedBy":"ONEDATA","dateModified":"2009-08-19","deletedIndicator":"No"},{"value":"platelet aggregation: % of collagen induced aggregation vs. control","valueDescription":"Platelet Aggregation Induction Collagen Percentage Control Group","ValueMeaning":{"publicId":"2915703","version":"1","preferredName":"Platelet Aggregation Induction Collagen Percentage Control Group","longName":"2915703","preferredDefinition":"Platelet Aggregation Induction involves initiation of activities of biologic molecules or complexes involved in the attachment of platelets to one another. Induced by a number of agents (e.g., thrombin, collagen), platelet aggregation is part of the mechanism leading to the formation of a thrombus.:A family of large fibrous proteins that are the main components of connective tissue and are responsible for maintaining tissue structure.:A fraction or ratio with 100 understood as the denominator.:A group used as a standard of comparison in a control experiment.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Positive Regulation of Platelet Aggregation Process","conceptCode":"C40712","definition":"Any platelet aggregation process that increases the rate, frequency or extent of platelet aggregation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Collagen","conceptCode":"C16447","definition":"A family of large fibrous proteins that are the main components of connective tissue and are responsible for maintaining tissue structure.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Percentage","conceptCode":"C25613","definition":"A fraction or ratio with 100 understood as the denominator.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Control Group","conceptCode":"C28143","definition":"A group used as a standard of comparison in a control experiment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6E331B3E-824C-F896-E040-BB89AD433DA4","latestVersionIndicator":"Yes","beginDate":"2009-07-08","endDate":null,"createdBy":"UMLLOADER_CANANOLPRD","dateCreated":"2009-07-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7180DFAA-0E21-2524-E040-BB89AD430F45","beginDate":null,"endDate":null,"createdBy":"UMLLOADER_CANANOLPRD","dateCreated":"2009-08-19","modifiedBy":"ONEDATA","dateModified":"2009-08-19","deletedIndicator":"No"},{"value":"platelet aggregation: is above threshold?","valueDescription":"Platelet Aggregation Above Threshold Flag","ValueMeaning":{"publicId":"2915704","version":"1","preferredName":"Platelet Aggregation Above Threshold Flag","longName":"2915704","preferredDefinition":"The accumulation and adherence of platelets to form a clot or thrombus. When injury or bleeding occurs, platelets clump together at the site of injury; they expand and adhere to the injured area, thereby acting as a plug to reduce the bleeding. Platelet dysfunction can result in blood clotting and bleeding disorders.:In a place or position that is higher.:The lowest limit at which something becomes detectable or relevant.:An indicator that can be set or unset in order to signal whether a particular condition is true.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Platelet Aggregation Process","conceptCode":"C16999","definition":"Any cell adhesion process that involves the association of platelets via adhesion molecules.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Above","conceptCode":"C75329","definition":"In a place or position that is higher.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Threshold","conceptCode":"C48228","definition":"The lowest limit at which something becomes detectable or relevant.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Flag","conceptCode":"C43578","definition":"An indicator that can be set or unset in order to signal whether a particular condition is true.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6E331B3E-8271-F896-E040-BB89AD433DA4","latestVersionIndicator":"Yes","beginDate":"2009-07-08","endDate":null,"createdBy":"UMLLOADER_CANANOLPRD","dateCreated":"2009-07-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7180DFAA-0E32-2524-E040-BB89AD430F45","beginDate":null,"endDate":null,"createdBy":"UMLLOADER_CANANOLPRD","dateCreated":"2009-08-19","modifiedBy":"ONEDATA","dateModified":"2009-08-19","deletedIndicator":"No"},{"value":"proliferation: % of control","valueDescription":"Proliferation Percentage Control Group","ValueMeaning":{"publicId":"2915705","version":"1","preferredName":"Proliferation Percentage Control Group","longName":"2915705","preferredDefinition":"Growth and reproduction of new similar forms, e.g. cells, buds, or offspring.:A fraction or ratio with 100 understood as the denominator.:A group used as a standard of comparison in a control experiment.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Proliferation","conceptCode":"C37897","definition":"Proliferation; a rapid increase in number.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Percentage","conceptCode":"C25613","definition":"A fraction or ratio with 100 understood as the denominator.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Control Group","conceptCode":"C28143","definition":"A group used as a standard of comparison in a control experiment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6E331B3E-8295-F896-E040-BB89AD433DA4","latestVersionIndicator":"Yes","beginDate":"2009-07-08","endDate":null,"createdBy":"UMLLOADER_CANANOLPRD","dateCreated":"2009-07-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7180DFAA-0E43-2524-E040-BB89AD430F45","beginDate":null,"endDate":null,"createdBy":"UMLLOADER_CANANOLPRD","dateCreated":"2009-08-19","modifiedBy":"ONEDATA","dateModified":"2009-08-19","deletedIndicator":"No"},{"value":"proliferation: ratio of cell line1 to cell line 2","valueDescription":"Proliferation Cell Count Ratio","ValueMeaning":{"publicId":"2915706","version":"1","preferredName":"Proliferation Cell Count Ratio","longName":"2915706","preferredDefinition":"Growth and reproduction of new similar forms, e.g. cells, buds, or offspring.:A procedure to determine the number of cells in a sample. Also used to mean the result of such a procedure.:Quotient of quantities of the same kind for different components within the same system.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Proliferation","conceptCode":"C37897","definition":"Proliferation; a rapid increase in number.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Cell Count","conceptCode":"C48938","definition":"A procedure to determine the number of cells in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Ratio","conceptCode":"C44256","definition":"Quotient of quantities of the same kind for different components within the same system.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6E331B3E-82B9-F896-E040-BB89AD433DA4","latestVersionIndicator":"Yes","beginDate":"2009-07-08","endDate":null,"createdBy":"UMLLOADER_CANANOLPRD","dateCreated":"2009-07-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7180DFAA-0E54-2524-E040-BB89AD430F45","beginDate":null,"endDate":null,"createdBy":"UMLLOADER_CANANOLPRD","dateCreated":"2009-08-19","modifiedBy":"ONEDATA","dateModified":"2009-08-19","deletedIndicator":"No"},{"value":"purity: % purity for sample","valueDescription":"Purity Percentage Purity","ValueMeaning":{"publicId":"2915707","version":"1","preferredName":"Purity Percentage Purity","longName":"2915707","preferredDefinition":"A quantitative assessment of the homogeneity or uniformity of a mixture. Alternatively, purity refers to the degree of being free of contaminants or heterogeneous components.:A fraction or ratio with 100 understood as the denominator.:A quantitative assessment of the homogeneity or uniformity of a mixture. Alternatively, purity refers to the degree of being free of contaminants or heterogeneous components.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Purity","conceptCode":"C62352","definition":"A quantitative assessment of the homogeneity or uniformity of a mixture. Alternatively, purity refers to the degree of being free of contaminants or heterogeneous components.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Percentage","conceptCode":"C25613","definition":"A fraction or ratio with 100 understood as the denominator.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Purity","conceptCode":"C62352","definition":"A quantitative assessment of the homogeneity or uniformity of a mixture. Alternatively, purity refers to the degree of being free of contaminants or heterogeneous components.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6E331B3E-82DD-F896-E040-BB89AD433DA4","latestVersionIndicator":"Yes","beginDate":"2009-07-08","endDate":null,"createdBy":"UMLLOADER_CANANOLPRD","dateCreated":"2009-07-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7180DFAA-0E65-2524-E040-BB89AD430F45","beginDate":null,"endDate":null,"createdBy":"UMLLOADER_CANANOLPRD","dateCreated":"2009-08-19","modifiedBy":"ONEDATA","dateModified":"2009-08-19","deletedIndicator":"No"},{"value":"relaxivity: R1","valueDescription":"Relaxivity Longitudinal Relaxation Rate","ValueMeaning":{"publicId":"2915708","version":"1","preferredName":"Relaxivity Longitudinal Relaxation Rate","longName":"2915708","preferredDefinition":"A measure of the ability of magnetic compounds to increase the relaxation rates of the surrounding water proton spins in nuclear magnetic resonance applications.:The relaxation rate of the net nuclear spin polarization in the direction of the magnetic field of a spectrometer back to its equilibrium value.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Relaxivity","conceptCode":"C63853","definition":"A measure of the ability of magnetic compounds to increase the relaxation rates of the surrounding water proton spins in nuclear magnetic resonance applications.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Longitudinal Relaxation Rate","conceptCode":"C80361","definition":"The relaxation rate of the net nuclear spin polarization in the direction of the magnetic field of a spectrometer back to its equilibrium value.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6E331B3E-8300-F896-E040-BB89AD433DA4","latestVersionIndicator":"Yes","beginDate":"2009-07-08","endDate":null,"createdBy":"UMLLOADER_CANANOLPRD","dateCreated":"2009-07-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7180DFAA-0E76-2524-E040-BB89AD430F45","beginDate":null,"endDate":null,"createdBy":"UMLLOADER_CANANOLPRD","dateCreated":"2009-08-19","modifiedBy":"ONEDATA","dateModified":"2009-08-19","deletedIndicator":"No"},{"value":"relaxivity: R2","valueDescription":"Relaxivity Transverse Spin Relaxation Rate","ValueMeaning":{"publicId":"2915709","version":"1","preferredName":"Relaxivity Transverse Spin Relaxation Rate","longName":"2915709","preferredDefinition":"A measure of the ability of magnetic compounds to increase the relaxation rates of the surrounding water proton spins in nuclear magnetic resonance applications.:The relaxation rate of spin polarization in the plane perpendicular to the magnetic field of a spectrometer back to zero as precessing spins loose coherence with each other.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Relaxivity","conceptCode":"C63853","definition":"A measure of the ability of magnetic compounds to increase the relaxation rates of the surrounding water proton spins in nuclear magnetic resonance applications.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Transverse Spin Relaxation Rate","conceptCode":"C80362","definition":"The relaxation rate of spin polarization in the plane perpendicular to the magnetic field of a spectrometer back to zero as precessing spins loose coherence with each other.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6E331B3E-8323-F896-E040-BB89AD433DA4","latestVersionIndicator":"Yes","beginDate":"2009-07-08","endDate":null,"createdBy":"UMLLOADER_CANANOLPRD","dateCreated":"2009-07-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7180DFAA-0E87-2524-E040-BB89AD430F45","beginDate":null,"endDate":null,"createdBy":"UMLLOADER_CANANOLPRD","dateCreated":"2009-08-19","modifiedBy":"ONEDATA","dateModified":"2009-08-19","deletedIndicator":"No"},{"value":"relaxivity: T1","valueDescription":"Relaxivity Longitudinal Relaxation Time","ValueMeaning":{"publicId":"2915710","version":"1","preferredName":"Relaxivity Longitudinal Relaxation Time","longName":"2915710","preferredDefinition":"A measure of the ability of magnetic compounds to increase the relaxation rates of the surrounding water proton spins in nuclear magnetic resonance applications.:The time it takes for the net nuclear spin in the plane that is parallel to the magnetic field of a spectrometer to return to its equilibrium value.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Relaxivity","conceptCode":"C63853","definition":"A measure of the ability of magnetic compounds to increase the relaxation rates of the surrounding water proton spins in nuclear magnetic resonance applications.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Longitudinal Relaxation Time","conceptCode":"C80363","definition":"The time it takes for the net nuclear spin in the plane that is parallel to the magnetic field of a spectrometer to return to its equilibrium value.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6E331B3E-8346-F896-E040-BB89AD433DA4","latestVersionIndicator":"Yes","beginDate":"2009-07-08","endDate":null,"createdBy":"UMLLOADER_CANANOLPRD","dateCreated":"2009-07-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7180DFAA-0E98-2524-E040-BB89AD430F45","beginDate":null,"endDate":null,"createdBy":"UMLLOADER_CANANOLPRD","dateCreated":"2009-08-19","modifiedBy":"ONEDATA","dateModified":"2009-08-19","deletedIndicator":"No"},{"value":"relaxivity: T2","valueDescription":"Relaxivity Transverse Spin Relaxation Time","ValueMeaning":{"publicId":"2915711","version":"1","preferredName":"Relaxivity Transverse Spin Relaxation Time","longName":"2915711","preferredDefinition":"A measure of the ability of magnetic compounds to increase the relaxation rates of the surrounding water proton spins in nuclear magnetic resonance applications.:The time it takes for the net nuclear spin in the plane that is perpendicular to the magnetic field of a spectrometer to decay to zero.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Relaxivity","conceptCode":"C63853","definition":"A measure of the ability of magnetic compounds to increase the relaxation rates of the surrounding water proton spins in nuclear magnetic resonance applications.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Transverse Spin Relaxation Time","conceptCode":"C80364","definition":"The time it takes for the net nuclear spin in the plane that is perpendicular to the magnetic field of a spectrometer to decay to zero.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6E331B3E-8369-F896-E040-BB89AD433DA4","latestVersionIndicator":"Yes","beginDate":"2009-07-08","endDate":null,"createdBy":"UMLLOADER_CANANOLPRD","dateCreated":"2009-07-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7180DFAA-0EA9-2524-E040-BB89AD430F45","beginDate":null,"endDate":null,"createdBy":"UMLLOADER_CANANOLPRD","dateCreated":"2009-08-19","modifiedBy":"ONEDATA","dateModified":"2009-08-19","deletedIndicator":"No"},{"value":"ROS generation: % of control","valueDescription":"Oxygen Radical Generation Percentage Control Group","ValueMeaning":{"publicId":"2915712","version":"1","preferredName":"Oxygen Radical Generation Percentage Control Group","longName":"2915712","preferredDefinition":"An oxygen species that carries an unpaired electron (e.g., the hydroxyl radical and the superoxide anion). These radicals are very powerful oxidizing agents and cause structural damage to proteins and nucleic acids. They mediate the damaging effects of ionizing radiation. (from Online Medical Dictionary):The act of bringing into being.:A fraction or ratio with 100 understood as the denominator.:A group used as a standard of comparison in a control experiment.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Oxygen Radical","conceptCode":"C1421","definition":"Organic or inorganic chemicals that contain an oxygen atom with an unpaired electron. This unstable electron configuration causes these chemicals to be highly reactive with other molecules.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Generation","conceptCode":"C48151","definition":"The act of bringing into being.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Percentage","conceptCode":"C25613","definition":"A fraction or ratio with 100 understood as the denominator.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Control Group","conceptCode":"C28143","definition":"A group used as a standard of comparison in a control experiment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6E331B3E-838E-F896-E040-BB89AD433DA4","latestVersionIndicator":"Yes","beginDate":"2009-07-08","endDate":null,"createdBy":"UMLLOADER_CANANOLPRD","dateCreated":"2009-07-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7180DFAA-0EBA-2524-E040-BB89AD430F45","beginDate":null,"endDate":null,"createdBy":"UMLLOADER_CANANOLPRD","dateCreated":"2009-08-19","modifiedBy":"ONEDATA","dateModified":"2009-08-19","deletedIndicator":"No"},{"value":"size: PDI","valueDescription":"Size Polydispersity Index","ValueMeaning":{"publicId":"2915713","version":"1","preferredName":"Size Polydispersity Index","longName":"2915713","preferredDefinition":"The physical magnitude of something.:A measure of the distribution of molecular weights in a given polymer sample. The PDI calculated is the weight average molecular weight divided by the number average molecular weight. It indicates the distribution of individual molecular weights in a population of polymers.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Size","conceptCode":"C25681","definition":"The physical magnitude of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Polydispersity Index","conceptCode":"C63852","definition":"A measure of the distribution of molecular weights in a given polymer sample. The PDI calculated is the weight average molecular weight divided by the number average molecular weight. It indicates the distribution of individual molecular weights in a population of polymers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6E331B3E-83B1-F896-E040-BB89AD433DA4","latestVersionIndicator":"Yes","beginDate":"2009-07-08","endDate":null,"createdBy":"UMLLOADER_CANANOLPRD","dateCreated":"2009-07-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7180DFAA-0ECB-2524-E040-BB89AD430F45","beginDate":null,"endDate":null,"createdBy":"UMLLOADER_CANANOLPRD","dateCreated":"2009-08-19","modifiedBy":"ONEDATA","dateModified":"2009-08-19","deletedIndicator":"No"},{"value":"size: size","valueDescription":"Size","ValueMeaning":{"publicId":"2934402","version":"1","preferredName":"Size","longName":"2934402","preferredDefinition":"Size; the physical magnitude of something.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Size","conceptCode":"C25681","definition":"The physical magnitude of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"71806156-0917-0D67-E040-BB89AD435F80","latestVersionIndicator":"Yes","beginDate":"2009-08-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2009-08-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7180DFAA-0ED4-2524-E040-BB89AD430F45","beginDate":null,"endDate":null,"createdBy":"UMLLOADER_CANANOLPRD","dateCreated":"2009-08-19","modifiedBy":"ONEDATA","dateModified":"2009-08-19","deletedIndicator":"No"},{"value":"surface: charge","valueDescription":"Surface Charge","ValueMeaning":{"publicId":"2915717","version":"1","preferredName":"Surface Charge","longName":"2915717","preferredDefinition":"The extended two-dimensional outer boundary of a three-dimensional object.:The quantity of unbalanced electricity in a body (either positive or negative) and construed as an excess or deficiency of electrons.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Surface","conceptCode":"C25245","definition":"The extended two-dimensional outer boundary of a three-dimensional object.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Charge","conceptCode":"C48050","definition":"The quantity of unbalanced electricity in a body (either positive or negative) and construed as an excess or deficiency of electrons.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6E331B3E-843D-F896-E040-BB89AD433DA4","latestVersionIndicator":"Yes","beginDate":"2009-07-08","endDate":null,"createdBy":"UMLLOADER_CANANOLPRD","dateCreated":"2009-07-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7180DFAA-0EE5-2524-E040-BB89AD430F45","beginDate":null,"endDate":null,"createdBy":"UMLLOADER_CANANOLPRD","dateCreated":"2009-08-19","modifiedBy":"ONEDATA","dateModified":"2009-08-19","deletedIndicator":"No"},{"value":"surface: surface area","valueDescription":"Surface Area","ValueMeaning":{"publicId":"2754200","version":"1","preferredName":"Surface Area","longName":"2754200","preferredDefinition":"The extent of a 2-dimensional surface enclosed within a boundary.:The extended two-dimensional outer boundary of a three-dimensional object.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Surface","conceptCode":"C25245","definition":"The extended two-dimensional outer boundary of a three-dimensional object.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Area","conceptCode":"C25244","definition":"The extent of a 2-dimensional surface enclosed within a boundary.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4E6299D1-2F8B-36B9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-05-29","endDate":null,"createdBy":"UMLLOADER_CANANOLAB","dateCreated":"2008-05-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7180DFAA-0EF6-2524-E040-BB89AD430F45","beginDate":null,"endDate":null,"createdBy":"UMLLOADER_CANANOLPRD","dateCreated":"2009-08-19","modifiedBy":"ONEDATA","dateModified":"2009-08-19","deletedIndicator":"No"},{"value":"surface: zeta potential","valueDescription":"Surface Zeta Potential","ValueMeaning":{"publicId":"2915718","version":"1","preferredName":"Surface Zeta Potential","longName":"2915718","preferredDefinition":"The extended two-dimensional outer boundary of a three-dimensional object.:The magnitude of the electrical potential as generated by ion accumulation at the particulate surface. This surface consists of two layers, the Stern layer and the diffuse layer, which comprise an electrical double-layer. The measurement of the electrical potential provides important information regarding the dispersion mechanism, the degree of particle dispersion and the electrostatic potential of the sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Surface","conceptCode":"C25245","definition":"The extended two-dimensional outer boundary of a three-dimensional object.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Zeta Potential","conceptCode":"C62354","definition":"The magnitude of the electrical potential as generated by ion accumulation at the particulate surface. This surface consists of two layers, the Stern layer and the diffuse layer, which comprise an electrical double-layer. The measurement of the electrical potential provides important information regarding the dispersion mechanism, the degree of particle dispersion and the electrostatic potential of the sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6E331B3E-8472-F896-E040-BB89AD433DA4","latestVersionIndicator":"Yes","beginDate":"2009-07-08","endDate":null,"createdBy":"UMLLOADER_CANANOLPRD","dateCreated":"2009-07-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7180DFAA-0F07-2524-E040-BB89AD430F45","beginDate":null,"endDate":null,"createdBy":"UMLLOADER_CANANOLPRD","dateCreated":"2009-08-19","modifiedBy":"ONEDATA","dateModified":"2009-08-19","deletedIndicator":"No"},{"value":"cell viability: LC50","valueDescription":"Cell Survival Plaque Forming Unit Equivalent 1000 Mouse LD50","ValueMeaning":{"publicId":"2946023","version":"1","preferredName":"Cell Survival Plaque Forming Unit Equivalent 1000 Mouse LD50","longName":"2946023v1.00","preferredDefinition":"The smallest units of living structure capable of independent existence, composed of a membrane-enclosed mass of protoplasm and containing a nucleus or nucleoid._Continuance of life or existence especially under adverse conditions; includes methods and philosophy of survival._An amount of toxin that would kill 50% of 1000 mice, expressed as an equivalent amount of plaque-forming units.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cell","conceptCode":"C12508","definition":"The smallest units of living structure capable of independent existence, composed of a membrane-enclosed mass of protoplasm and containing a nucleus or nucleoid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Survival","conceptCode":"C17177","definition":"Continuance of life or existence especially under adverse conditions; includes methods and philosophy of survival.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Plaque Forming Unit Equivalent 1000 Mouse LD50","conceptCode":"C73575","definition":"An amount of toxin that would kill 50% of 1000 mice, expressed as an equivalent amount of plaque-forming units.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"746944AF-440A-DCDB-E040-BB89AD437B02","latestVersionIndicator":"Yes","beginDate":"2009-09-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-09-25","modifiedBy":"KUMMEROA","dateModified":"2023-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"746944AF-4423-DCDB-E040-BB89AD437B02","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2009-09-25","modifiedBy":"ONEDATA","dateModified":"2009-09-25","deletedIndicator":"No"},{"value":"gsh homeostasis: % of control","valueDescription":"Glutathione Homeostasis Percentage Control Group","ValueMeaning":{"publicId":"2915690","version":"1","preferredName":"Glutathione Homeostasis Percentage Control Group","longName":"2915690","preferredDefinition":"A tripeptide comprised of three amino acids (cysteine, glutamic acid, and glycine) present in most mammalian tissue. Glutathione acts as an antioxidant, a free radical scavenger and as a detoxifying agent. Glutathione is also important as a cofactor for the enzyme glutathione peroxidase, in the uptake of amino acids and participates in leukotriene synthesis. Under the influence of glutathione S-transferase, glutathione can react with a number of harmful products, such as halides, epoxides and free radicals, to form harmless inactive products. In erythrocytes, these reactions prevent oxidative damage by reduction of methemoglobin and peroxides. Glutathione is also involved in the formation and maintenance of disulfide bonds in proteins and in transport of amino acids across cell membranes.:The regulation of a particular factor which attempts to keep that factor at an equilibrium or norm. This involves a feedback mechanism that recognizes any deviance from the norm and initiates counter-measures to return the factor back to its desired level. An example of homeostasis is temperature regulation. (Biology Online Dictionary):A fraction or ratio with 100 understood as the denominator.:A group used as a standard of comparison in a control experiment.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Glutathione","conceptCode":"C523","definition":"A tripeptide comprised of three amino acids (cysteine, glutamic acid, and glycine) present in most mammalian tissue. Glutathione acts as an antioxidant, a free radical scavenger and a detoxifying agent. Glutathione is also important as a cofactor for the enzyme glutathione peroxidase, in the uptake of amino acids, and in the synthesis of leukotrienes. As a substrate for glutathione S-transferase, this agent reacts with a number of harmful chemical species, such as halides, epoxides and free radicals, to form harmless inactive products. In erythrocytes, these reactions prevent oxidative damage through the reduction of methemoglobin and peroxides. Glutathione is also involved in the formation and maintenance of disulfide bonds in proteins and in the transport of amino acids across cell membranes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Homeostatic Process","conceptCode":"C25989","definition":"The body's maintenance of a consistent internal environment within a narrow range of variation. It is important to the continuation of life.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Percentage","conceptCode":"C25613","definition":"A fraction or ratio with 100 understood as the denominator.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Control Group","conceptCode":"C28143","definition":"A group used as a standard of comparison in a control experiment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6E331B3E-8073-F896-E040-BB89AD433DA4","latestVersionIndicator":"Yes","beginDate":"2009-07-08","endDate":null,"createdBy":"UMLLOADER_CANANOLPRD","dateCreated":"2009-07-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"745580E8-3695-8FA9-E040-BB89AD433702","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2009-09-24","modifiedBy":"ONEDATA","dateModified":"2009-09-24","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435019","version":"1","preferredName":"Conceptual Entity","preferredDefinition":"An organizational header for concepts representing mostly abstract entities.","longName":"C20181","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D8-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2229718","version":"1","preferredName":"Name","preferredDefinition":"The words or language units by which a thing is known.","longName":"C42614","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Name","conceptCode":"C42614","definition":"The words or language units by which a thing is known.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F6EF4E2B-76AE-72C1-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-16","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-05-16","modifiedBy":"ONEDATA","dateModified":"2005-05-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7180DFAA-0BD5-2524-E040-BB89AD430F45","latestVersionIndicator":"Yes","beginDate":"2009-08-19","endDate":null,"createdBy":"UMLLOADER_CANANOLPRD","dateCreated":"2009-08-19","modifiedBy":"KUMMEROA","dateModified":"2023-08-22","changeDescription":"9/22/11 Released caNanoLab v1.5 content per Sue Pan as part of model cleanup task.","administrativeNotes":"2023.8.22 Updated PV def for 'No Value Exists'. ak","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2915522","version":"1.5","longName":"caNanoLab","context":"NCIP","ClassificationSchemeItems":[{"publicId":"10000157","version":"1","longName":"gov.nih.nci.cananolab.domain.common","context":"NCIP"}]}],"AlternateNames":[{"name":"Datum:name","type":"UML Class:UML Attr","context":"NCIP"},{"name":"gov.nih.nci.cananolab.domain.common.Datum.name","type":"UML Qualified Attr","context":"NCIP"}],"ReferenceDocuments":[{"name":"Data Element Data Name DatumName does not have Preferred Question Text","type":"Preferred Question Text","description":"Data Element Data Name DatumName does not have Preferred Question Text","url":null,"context":"NCIP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7180E9BB-0069-B992-E040-BB89AD4329B0","latestVersionIndicator":"Yes","beginDate":"2009-08-19","endDate":null,"createdBy":"UMLLOADER_CANANOLPRD","dateCreated":"2009-08-19","modifiedBy":"CHILLIJ","dateModified":"2011-09-22","changeDescription":"9/22/11 Released caNanoLab v1.5 content per Sue Pan as part of model cleanup task.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}